Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.6416 USD | -2.79% | +1.42% | -13.95% |
04-04 | North American Morning Briefing : Focus Turns to -2- | DJ |
04-04 | Traws Pharma, Inc. Announces Chief Executive Office Changes | CI |
Sales 2024 * | 210K 287K | Sales 2025 * | 300K 410K | Capitalization | 13.53M 18.49M |
---|---|---|---|---|---|
Net income 2024 * | -23M -31.43M | Net income 2025 * | -28M -38.26M | EV / Sales 2024 * | 64.4 x |
Net cash position 2024 * | - 0 | Net cash position 2025 * | - 0 | EV / Sales 2025 * | 45.1 x |
P/E ratio 2024 * |
-0.74
x | P/E ratio 2025 * |
-0.77
x | Employees | 18 |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 81.1% |
Latest transcript on Traws Pharma, Inc.
1 day | -2.79% | ||
1 week | +1.42% | ||
Current month | -2.79% | ||
1 month | -35.54% | ||
3 months | -10.52% | ||
6 months | -1.09% | ||
Current year | -13.95% |
Managers | Title | Age | Since |
---|---|---|---|
Steven Fruchtman
PSD | President | 73 | 15-01-18 |
Mark Guerin
DFI | Director of Finance/CFO | 55 | 13-08-31 |
Meena Arora
CTO | Chief Tech/Sci/R&D Officer | - | 23-10-23 |
Members of the board | Title | Age | Since |
---|---|---|---|
James Marino
BRD | Director/Board Member | 74 | 15-06-30 |
Jack Stover
BRD | Director/Board Member | 69 | 16-05-22 |
Mary Shoemaker
BRD | Director/Board Member | 63 | 20-03-31 |
Date | Price | Change | Volume |
---|---|---|---|
24-05-02 | 0.6416 | -2.79% | 90,968 |
24-05-01 | 0.66 | 0.00% | 30,468 |
24-04-30 | 0.66 | +3.13% | 18,447 |
24-04-29 | 0.64 | +3.11% | 24,839 |
24-04-26 | 0.6207 | -1.87% | 45,200 |
Delayed Quote Nasdaq, May 02, 2024 at 04:30 pm
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-13.95% | 13.92M | |
+26.28% | 42.68B | |
-3.99% | 42.4B | |
+45.32% | 40.04B | |
-6.20% | 28.31B | |
+6.36% | 24.94B | |
-21.47% | 18.96B | |
+27.58% | 12.3B | |
-2.75% | 11.95B | |
-2.02% | 11.55B |
- Stock Market
- Equities
- TRAW Stock